CSF3 and therapy-related myeloid neoplasm: After first primary female breast cancer, chemotherapy ± radiation (without G-CSF) significantly increased risk of tMN development compared to no chemotherapy or radiation (±G-CSF; HR = 1.91, 95% CI = 1.49 to 2.4, P < .0001; Table 1).